Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.470
+0.030 (0.68%)
Apr 29, 2026, 3:00 PM CST

SHA:600572 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
856.441,6741,3222,5702,4682,573
Cash & Short-Term Investments
856.441,6741,3222,5702,4682,573
Cash Growth
11.15%26.60%-48.56%4.13%-4.09%63.19%
Accounts Receivable
1,8881,5201,6651,7561,6381,671
Other Receivables
74.5862.4787.7438.2259.4184.42
Receivables
1,9631,5821,7531,7941,6971,755
Inventory
1,0871,2301,2661,3331,1281,044
Prepaid Expenses
--0.260.610.891.02
Other Current Assets
975.4671.9878.1877.26101.7492.17
Total Current Assets
4,8814,5584,4195,7755,3955,466
Property, Plant & Equipment
2,8092,8743,0473,0483,2203,251
Long-Term Investments
1,7531,8971,7741,7231,6291,881
Goodwill
184.72184.72184.72184.72184.72184.72
Other Intangible Assets
365.3371.95349.19355.45390.79362.43
Long-Term Deferred Tax Assets
34.6738.8341.1678.9455.4627.5
Long-Term Deferred Charges
20.1822.5967.4646.3540.6666.81
Other Long-Term Assets
171.437.4419.3125.8614.8234.78
Total Assets
10,2209,9849,90211,23810,93111,274
Accounts Payable
889.22955.57984.41819.53629.13540.19
Accrued Expenses
220.55216.89963.411,2051,005873.5
Short-Term Debt
21.11157.42210.56849.71717.731,344
Current Portion of Long-Term Debt
-105.391.0777.79138.63129.65
Current Portion of Leases
--2.234.46.154.63
Current Income Taxes Payable
107.379344.8456.4551.3828.5
Current Unearned Revenue
34.7937.237.6843.65113.336.68
Other Current Liabilities
1,188873.02182.23115.87128.07210.8
Total Current Liabilities
2,4612,4382,5163,1732,7893,168
Long-Term Debt
40.0240117.87305.03330.39.5
Long-Term Leases
3.410.992.050.723.974
Long-Term Unearned Revenue
106.98109.88116.21141.11154.22146.83
Long-Term Deferred Tax Liabilities
240.96241.95235.6268.27328.79310.3
Other Long-Term Liabilities
0.970.960.940.930.920.92
Total Liabilities
2,8542,8322,9893,8893,6073,639
Common Stock
2,5372,5352,5832,5702,5702,570
Additional Paid-In Capital
291.41284.02285.66210.32149.54359.76
Retained Earnings
4,3674,1684,2514,2614,1944,271
Treasury Stock
---299.99---
Comprehensive Income & Other
61.360.15-0.11-0.010.10.27
Total Common Equity
7,2567,0476,8207,0416,9147,201
Minority Interest
109.69105.1192.97308.58410.18434.01
Shareholders' Equity
7,3667,1526,9137,3507,3247,635
Total Liabilities & Equity
10,2209,9849,90211,23810,93111,274
Total Debt
64.54303.7423.771,2381,1971,492
Net Cash (Debt)
791.91,370898.341,3321,2711,082
Net Cash Growth
60.22%52.51%-32.57%4.81%17.53%-
Net Cash Per Share
0.320.550.350.520.500.42
Filing Date Shares Outstanding
2,5442,4342,5192,5702,5702,570
Total Common Shares Outstanding
2,5442,4342,5192,5702,5702,570
Working Capital
2,4202,1201,9022,6032,6062,298
Book Value Per Share
2.852.892.712.742.692.80
Tangible Book Value
6,7066,4906,2866,5016,3386,654
Tangible Book Value Per Share
2.642.672.492.532.472.59
Buildings
--2,4272,2502,1382,055
Machinery
--2,7652,6552,2791,888
Construction In Progress
--139.45238.37661.931,068
Source: S&P Global Market Intelligence. Standard template. Financial Sources.